Here, we characterized a subset of breast cancer patients with hyperactivated status of ferroptosis and necroptosis pathway and overexpressed NDUFA13, in which activation of ferroptosis promoting the infiltration of anti-tumor cells like Tgd, therefore, might correlate with better responsiveness of immunotherapy in breast cancer. Here, NDUFA13 is linked to breast carcinoma.